Andere talen Coherus BioSciences, Inc.

Aandelen

CHRS

US19249H1032

Geschatte realtime Cboe BZX Andere beurzen 21:34:28 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,035 ^USD	+5,44%		-1,93%	-39,04%

24/04	Coherus BioSciences, Inc. kondigt de presentatie aan van klinische gegevens voor CHS-114 tijdens de jaarlijkse bijeenkomst van de American Society of Clinical Oncology in 2024	CI
21/03	COHERUS BIOSCIENCES, INC. : HC Wainwright bevestigt koopadvies	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Coherus Announces Presentation at the 2024 American Society of Clinical Oncology Annual Meeting	25/04
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	24/04
Coherus BioSciences, Inc. Announces Presentation of Clinical Data for CHS-114 at 2024 American Society of Clinical Oncology Annual Meeting	24/04
Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting	08/04
Coherus BioSciences Shares Fall After Workforce Reduction Plan; Q4 Loss	14/03
Coherus Biosciences : Delta Airlines, KKR...les valeurs à suivre aujourd'hui à Wall Street -	14/03
Coherus Biosciences : trébuche au quatrième trimestre	14/03
Coherus BioSciences: Q4 Earnings Snapshot	13/03
Earnings Flash (CHRS) COHERUS BIOSCIENCES Reports Q4 Revenue $91.5M, vs. Street Est of $90.4M	13/03
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update	13/03
Coherus BioSciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	13/03
INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights	07/03
Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024	05/03
Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024	05/03
Bourse Zurich: le SMI ne parvient pas à remonter la pente	04/03
North American Morning Briefing : Stock Futures -2-	04/03
North American Morning Briefing : Stock Futures Hover At Start of Busy Week	04/03
Sandoz : finalise en avance le rachat du Cimerli	04/03
Coherus BioSciences Completes $170 Million Sale of Ophthalmology Franchise to Sandoz	04/03
L'IA, si t'en as pas, t'as raté ta vie (boursière)	04/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Coherus BioSciences, Inc.

Aandelen

CHRS

US19249H1032

Andere talen

Filters